Surrey Heartlands

Joint Formulary & PAD

Budesonide with formoterol (Fobumix Easyhaler) - Asthma

You are here : Home > Formulary Search > Budesonide with formoterol (Fobumix Easyhaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important

Fobumix Easyhaler 80/4.5 and 160/4.5 - licensed in children.

Cost-effective choice for AIR and MART.

Prescribe by BRAND.

 

Status 2

Blue
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important

Fobumix Easyhaler 320/9 - higher dose ICS/LABA for specialist recommendation only.

Prescribe by BRAND.

Documentation

Webpage
NICE NG80 - Asthma-diagnosis-monitoring-and-chronic-asthma-management
Webpage
How to use an Easyhaler inhaler - video
Patient resource
How to use an Easyhaler inhaler - Patient information leaflet
Patient resource
MART Fobumix Asthma Action plan - July 2019
Information
In-Check device for improving inhaler technique - Nov 16

PAD Profile

ChemicalSubstance :
Budesonide with formoterol (Fobumix Easyhaler)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics, MART action plans, maintenance and reliever therapy
Brand Names Include :
Fobumix Easyhaler
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Asthma
Supporting Documents :
5
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Budesonide with formoterol (Fobumix Easyhaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

06 Mar 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Fostair® (beclometasone / formoterol) metered dose inhaler is the locally preferred ICS/LABA.
Fostair Nexthaler ® breath-actuated inhaler is the preferred dry powder ICS/LABA device.

If patient cannot tolerate formoterol, a salmeterol / fluticasone combination may be indicated.
Combisal® (fluticasone / salmeterol) metered dose inhaler is the locally preferred device.
Seretide Accuhaler® is the locally preferred futicasone/salmeterol breath-actuated device.

NOTE: 
- Fobumix Easyhaler® is not one of the locally preferred devices

- A MART action plan is available for patients to use with this device - see MART action plan document below

Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion.

See Asthma Guidelines below.